Holen Sie sich die Stockscreener-App
9.80
0.51%
-0.05
Schlusskurs vom Vortag:
$9.85
Offen:
$9.71
24-Stunden-Volumen:
40,456
Relative Volume:
0.11
Marktkapitalisierung:
$399.18M
Einnahmen:
$825.37M
Nettoeinkommen (Verlust:
$-60.01M
KGV:
-6.5242
EPS:
-1.5021
Netto-Cashflow:
$-4.46M
1W Leistung:
+5.95%
1M Leistung:
+9.50%
6M Leistung:
-19.01%
1J Leistung:
-37.66%
1-Tages-Spanne:
$9.64
$9.94
1-Wochen-Bereich:
$9.2848
$9.95
52-Wochen-Spanne:
$8.50
$16.99
Orthofix Medical Inc Stock (OFIX) Company Profile
Firmenname
Orthofix Medical Inc
Sektor
Branche
Telefon
214-937-2000
Adresse
3451 PLANO PARKWAY, LEWISVILLE, TX
Compare OFIX vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OFIX
Orthofix Medical Inc
|
9.80 | 399.18M | 825.37M | -60.01M | -4.46M | -1.5021 |
ABT
Abbott Laboratories
|
98.61 | 170.62B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
93.39 | 119.46B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.48 | 112.95B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.14 | 63.97B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.72 | 50.56B | 6.30B | 1.07B | 1.09B | 1.8406 |
Orthofix Medical Inc Stock (OFIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-27 | Eingeleitet | TD Cowen | Hold |
| 2025-10-28 | Fortgesetzt | Stifel | Buy |
| 2025-01-22 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-11-08 | Hochstufung | Stifel | Hold → Buy |
| 2024-05-08 | Hochstufung | ROTH MKM | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
| 2023-09-12 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-09-12 | Herabstufung | Stifel | Buy → Hold |
| 2023-07-19 | Fortgesetzt | BTIG Research | Buy |
| 2022-03-04 | Hochstufung | Stifel | Hold → Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2019-10-29 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-06-21 | Eingeleitet | BTIG Research | Buy |
| 2017-06-14 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-05-23 | Eingeleitet | SunTrust | Buy |
| 2015-07-10 | Eingeleitet | Sidoti | Buy |
| 2013-05-09 | Herabstufung | Mizuho | Buy → Neutral |
| 2013-01-08 | Bestätigt | Mizuho | Buy |
| 2010-06-21 | Eingeleitet | Boenning & Scattergood | Outperform |
| 2010-03-09 | Bestätigt | Jefferies & Co | Buy |
| 2010-02-18 | Hochstufung | Susquehanna Financial | Neutral → Positive |
| 2010-01-22 | Eingeleitet | Jefferies & Co | Buy |
| 2009-11-03 | Hochstufung | Wells Fargo | Underperform → Market Perform |
| 2009-07-31 | Bestätigt | Jefferies & Co | Buy |
| 2009-07-31 | Hochstufung | Thomas Weisel | Market Weight → Overweight |
| 2009-05-26 | Bestätigt | Jefferies & Co | Buy |
| 2009-04-17 | Herabstufung | Wachovia | Mkt Perform → Underperform |
| 2009-02-19 | Eingeleitet | Canaccord Adams | Buy |
| 2008-07-07 | Herabstufung | Wachovia | Outperform → Mkt Perform |
Alle ansehen
Orthofix Medical Inc Aktie (OFIX) Neueste Nachrichten
Smith & Nephew plc (SNN) stock price, news, quote and history - Yahoo Finance UK
150 shares sold under a trading plan by Patrick Fisher at Orthofix Medical (OFIX). - Stock Titan
A fund bought Orthofix Medical (OFIX) shares twice in September. The second purchase was larger. - Stock Titan
[Form 4] Orthofix Medical Inc. Insider Trading Activity - Stock Titan
Orthofix stock holds near its yearly range as results guide the setup - AD HOC NEWS
(OFIX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Orthopedics Co. Investor Says Docs Hid 'Boys Club' Culture - Law360
Orthofix Medical Inc (OFIX) Insider Sell: President, Global Limb Recon Patrick Fisher Disposes of 150 Shares - GuruFocus
Orthofix Medical's Patrick Fisher Sells 150 Shares Under Rule 10b5-1 Trading Plan - Kalkine Media
Orthofix Medical (OFIX) officer sells shares in preset trading plan - Stock Titan
(OFIX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Orthofix (NASDAQ: OFIX) officer lines up 450-share sale after recent 1,295-share trade - Stock Titan
CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Maintains Target Price $13 - Moomoo
Juniper Investment Company, LLC Buys Orthofix Medical Inc (OFIX) -- Shares Look 30% Undervalued on GF Value - GuruFocus
Orthofix Medical (OFIX) Stock Sees Fair Value Cut After Analysts Trim Q2 Outlook - Yahoo Finance
Orthofix president Patrick Fisher sells $13,066 in stock By Investing.com - Investing.com Nigeria
Orthofix president Patrick Fisher sells $13,066 in stock By Investing.com - Investing.com India
Orthofix president Patrick Fisher sells $13,066 in stock By Investing.com - Investing.com UK
Orthofix president Patrick Fisher sells $13,066 in stock - Investing.com
Orthofix president Patrick Fisher sells $13,066 in stock - investing.com
Orthofix (OFIX) insider sale tied to RSU tax withholding - Stock Titan
Orthofix (OFIX) Stock: Finishes 3.62% Up at $10.59 on the Day; Price Setup: the Supplied Trading Band Runs From $10.06 to $11.12 under the Current SnapshotExtension Target - vinanet.vn
Juniper investment sells $402,744 in Orthofix Medical shares By Investing.com - Investing.com
Juniper investment sells $402,744 in Orthofix Medical shares By Investing.com - Investing.com Canada
Juniper investment sells $402,744 in Orthofix Medical shares By Investing.com - Investing.com India
Juniper investment sells $402,744 in Orthofix Medical shares By Investing.com - Investing.com
Orthofix Medical (NASDAQ: OFIX) logs new insider trades - Stock Titan
Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook - marketbeat.com
Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook - TradingView
Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook - TradingView
Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook - Yahoo Finance
Armistice Capital (OFIX) discloses 3.26M-share, 8.01% Orthofix Medical stake - Stock Titan
Orthofix Medical (OFIX) Slips 2.1% to $10.18 as Traders Eye Support ZoneTriple Bottom - vinanet.vn
OFIX 1H 2026: Limb Recon Leads, Spine Gains Traction, Europe’s Plot Twist - Orthopedics This Week
Orthofix at Canaccord Genuity conference: turnaround gains face spine test By Investing.com - Investing.com South Africa
Orthofix at Canaccord Genuity conference: turnaround gains face spine test - Investing.com
OFIX Q2 2026 Earnings: Narrower-Than-Expected Loss of -$0.39 Beats Estimates, Shares Edge LowerOperating Margin Analysis - vinanet.vn
(OFIX) Risk Channels and Responsive Allocation - Stock Traders Daily
Analysts Have Conflicting Sentiments on These Healthcare Companies: Orthofix Medical (OFIX), Rhythm Pharmaceuticals (RYTM) and Viatris (VTRS) - The Globe and Mail
CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Cuts Target Price to $13 - Moomoo
OFIX Maintains Buy Rating -- Price Target Lowered to $13.00 by C - GuruFocus
Orthofix Medical (NASDAQ:OFIX) Price Target Lowered to $13.00 at Canaccord Genuity Group - marketbeat.com
Dimensional Fund Advisors LP Trims Stock Holdings in Orthofix Medical Inc. $OFIX - MarketBeat
Orthofix Medical (OFIX) Holds Near $10.26 as Support at $9.75 Comes into FocusKAMA Signal - vinanet.vn
Orthofix Medical Inc. (OFIX): Analyzing the 34.43% Potential Upside in the Medical Devices Sector - directorstalkinterviews.com
CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Maintains Target Price $18 - Moomoo
Orthofix Medical (OFIX) Stock Sinks As One Off Growth Clouds Outlook - Sahm
Is Orthofix Medical Inc (OFIX) Positioning for Growth After Q2 E - GuruFocus
Orthofix Medical Inc (OFIX) (Q2 2026) Earnings Call Highlights: - GuruFocus
Earnings call transcript: Orthofix tops Q2 2026 estimates, lifts outlook By Investing.com - Investing.com Canada
Finanzdaten der Orthofix Medical Inc-Aktie (OFIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Orthofix Medical Inc-Aktie (OFIX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| PATRICK FISHER | Officer |
Sep 01 '26 |
Proposed Sale |
9.39 |
450 |
4,226 |
0 |
| Fisher Patrick | President, Global Limb Recon |
Sep 01 '26 |
Sale |
9.39 |
150 |
1,408 |
51,069 |
| Fisher Patrick | President, Global Limb Recon |
Aug 18 '26 |
Sale |
10.09 |
1,295 |
13,067 |
51,219 |
| McPherron Aviva | Pres, Global Ops & Qual |
Jun 18 '26 |
Sale |
9.38 |
3,670 |
34,425 |
66,330 |
| HENNEMAN JOHN B III | Director |
May 07 '26 |
Buy |
12.26 |
5,000 |
61,295 |
90,809 |
| Engine Capital Management, LP | 10% Owner |
May 07 '26 |
Buy |
12.18 |
30,000 |
365,425 |
3,848,573 |
| Engine Capital Management, LP | 10% Owner |
May 06 '26 |
Buy |
12.23 |
41,946 |
512,916 |
3,821,285 |
| Engine Capital Management, LP | 10% Owner |
May 05 '26 |
Buy |
11.99 |
112,950 |
1,354,587 |
3,783,131 |
| Cedron Jorge Andres | CLO |
Apr 16 '26 |
Sale |
12.82 |
3,743 |
47,985 |
59,006 |
| Vitale Lucas | CP&BOO |
Mar 17 '26 |
Sale |
11.92 |
4,269 |
50,886 |
160,449 |
1.76%
2.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):